T. Lamonerie et al., IGF-2 AUTOCRINE STIMULATION IN TUMORIGENIC CLONES OF A HUMAN COLON-CARCINOMA CELL-LINE, International journal of cancer, 61(4), 1995, pp. 587-592
Clonal analysis has shown that the SW613-S human colon-carcinoma cell
line is heterogeneous: some cell clones display a high level of amplif
ication of the c-myc gene and are tumorigenic in nude mice, whereas ot
hers have a small number of copies of this gene and are non-tumorigeni
c. Tumorigenic clones can proliferate in a chemically defined serum-fr
ee medium, whereas non-tumorigenic clones cannot. Suramin, like anti-i
nsulin-like growth factor (IGF) or anti-IGF-1 receptor antibodies, eff
iciently inhibits the growth of tumorigenic clones in defined medium.
Inhibition by suramin or by anti-IGF antibodies can be reversed by pur
e IGF-1 or IGF-2. Pure IGF-1 or IGF-2 or culture medium conditioned by
tumorigenic clones can stimulate DNA synthesis in cells of non-tumori
genic clones. Go-culture with cells of tumorigenic clones sustains the
growth of non-tumorigenic clones in defined medium. Cells of both tum
origenic and non-tumorigenic clones express high-affinity IGF-1 recept
ors at their surface but tumorigenic clones produce on average 5 times
more IGF-1 and 25 times more IGF-2 than non-tumorigenic ones. These r
esults indicate that autocrine growth stimulation of tumorigenic clone
s by IGFs through the IGF-1 receptor is essential for their ability to
grow in defined medium. Since cells of tumorigenic clones produce IGF
-2 at levels 80 times higher than IGF-1 and since an antibody strictly
specific for IGF-1 has no effect on DNA synthesis in cells of tumorig
enic clones grown in defined medium, IGF-2 is very likely the main eff
ector in the autocrine loop. (C) 1995 Wiley-Liss, Inc.